Interestingly, Fortin Ensign et al. mention the ability of the RAC1-dependent activation of AKT2 to promote increased MMP-9 and invasive behavior in a review of Rho GTPase tumorigenic signaling in glioma cells [7]. The gene discussed is RAC1; the disease is central nervous system cancer.